Sharing this new authority provided to MA plans to allow step therapy for Part B drugs.

Leslie

Leslie Fried, JD
Senior Director, Center for Benefits Access
Office: 571.527.3992
xxxxxx@ncoa.org

National Council on Aging
Improving the lives of millions of older adults
251 18th Street South, Suite 500
Arlington, VA 22202
ncoa.org | @NCOAging

-----Original Message-----
From: HPMS <xxxxxx@cms.hhs.gov>
Sent: Tuesday, August 07, 2018 4:19 PM
To: Leslie Fried <xxxxxx@ncoa.org>
Subject: Prior Authorization and Step Therapy for Part B Drugs in Medicare Advantage

CMS is rescinding our September 17, 2012 HPMS memo "Prohibition on Imposing Mandatory Step Therapy for Access to Part B Drugs and Services," and issuing new guidance that recognizes Medicare Advantage (MA) plans may use step therapy for Part B drugs, beginning January 1, 2019, as part of a patient-centered care coordination program.
The information contained in this electronic mail and its attachments is privileged and confidential. It is intended for the use of the addressee and others specifically authorized to receive it. If you are not the intended recipient, you are prohibited from disseminating, distributing or copying this communication. If you have received this e-mail in error, please delete it and notify us by replying to this e-mail immediately.